FASTinov Commences Customer Evaluation at Prestigious University Hospital in Sevilla, Spain

FASTinov Commences Customer Evaluation at Prestigious University Hospital in Sevilla, Spain

September 18th 2023

(Porto, Portugal) – FASTinov, the global leader in rapid antimicrobial susceptibility testing (AST), is pleased to announce the commencement of a customer evaluation at one of the largest and most prestigious university hospitals. This collaboration marks a significant milestone for FASTinov as it continues to expand its footprint in healthcare institutions dedicated to advancing patient care and research.

The decision by the university hospital to initiate a customer evaluation underscores the growing recognition of FASTinov’s innovative AST solution within the medical community. Through this evaluation, the hospital aims to assess the performance and integration capabilities of FASTinov’s technology in its complex healthcare environment.

Nuno Afonso, CEO of FASTinov, expressed his excitement about this collaboration, stating,
“We are thrilled to partner with such a renowned institution in the healthcare sector. This customer evaluation represents an opportunity for us to showcase the effectiveness and versatility of our technology in addressing the unique needs of a leading university hospital.”

As one of the largest university hospitals, renowned for its commitment to excellence in patient care, research, and education, this collaboration holds immense promise for advancing the standard of care in infectious disease management. By leveraging FASTinov’s rapid AST solution, healthcare providers at the university hospital will have access to actionable insights that enable timely and targeted interventions for patients in need.

Dr. Cidália Pina Vaz, Chief Scientific Officer of FASTinov, emphasized the significance of this evaluation in advancing medical research and patient care.
“We are honoured to collaborate with the university hospital in this evaluation, as it aligns with our shared commitment to innovation and excellence in healthcare. Together, we aim to empower healthcare providers with the tools they need to make informed treatment decisions and improve patient outcomes.”

As FASTinov embarks on this customer evaluation journey with the prestigious university hospital, it reaffirms its dedication to driving positive change in healthcare through cutting-edge technology and collaborative partnerships.

About FASTinov

FASTinov is a leading innovator in rapid antimicrobial susceptibility testing, dedicated to revolutionizing patient care in sepsis contexts. With a mission to provide actionable same-shift results, FASTinov’s cutting-edge technology offers healthcare professionals unprecedented insights for targeted treatment decisions.

Share with friends